Systematic review / meta-analysis / 2022
Oral bergamot supplementation significantly improved serum total cholesterol, triglycerides, LDL-C, and HDL-C levels in adults.
A systematic review and meta-analysis of 14 randomized controlled trials evaluated the effects of oral bergamot supplementation on adult lipid profiles using a random-effects model. Bergamot supplementation significantly reduced total cholesterol (WMD: -63.60 mg/dL; 95% CI: -78.03 to -49.18; p < .001), triglycerides (WMD: -74.72 mg/dL; 95% CI: -83.58 to -65.87; p < .001), and LDL-C (WMD: -55.43 mg/dL; 95% CI: -67.26 to -43.60; p < .001), while significantly increasing HDL-C (WMD: 5.78 mg/dL; 95% CI: 3.27 to 8.28; p < .001). However, findings regarding nutraceuticals containing bergamot were inconsistent, and the authors noted that higher-quality studies are needed to further establish clinical efficacy.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- Adults from 14 trials
- What was measured
- Serum levels of total cholesterol, triglycerides, LDL-C, and HDL-C
THE PAPER
The effect of bergamot (KoksalGarry) supplementation on lipid profiles: A systematic review and meta-analysis of randomized controlled trials.
Sadeghi-Dehsahraei H, Esmaeili Gouvarchin Ghaleh H, Mirnejad R, Parastouei K. Phytother Res, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.